Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2006

01-02-2006 | Perspective

The effect of digital measurement software on photodynamic therapy

Authors: Siamak Ansari-Shahrezaei, Erdem Ergun, Michael Stur

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 2/2006

Login to get access

Abstract

Background

To investigate the effect of refraction-corrected digital measurement software on photodynamic therapy (PDT) treatment spot size.

Methods

Experimental study using a calibrated Gullstrand-type model eye. The axial length of the model eye was set to different values, ranging from 20 to 31 mm, and the PDT treatment spot sizes obtained from refraction-corrected digital measurement software and manual measurement with a fixed-magnification factor, as well as four different indirect contact laser lenses, were calculated and compared for a treatment spot with a diameter of 4 mm.

Results

The maximum deviation from the treating laser spot was +39.6% under myopic and +17.4% under hyperopic conditions when the refraction-corrected digital measurement software was used. The maximum deviation was +14.2% under myopic and +13.3% under hyperopic conditions when the manual measurement with the fixed-magnification factor was used.

Conclusions

The use of refraction-corrected digital measurement software produces a larger deviation from treating laser spot than the use of manual measurement with a fixed-magnification factor. Therefore, refraction-corrected digital measurement software might not be suitable for calculating the recommended PDT treatment spot size in eyes with high refractive errors.
Literature
1.
go back to reference Altman DG, Bland JM (1983) Measurement in medicine: the analysis of method comparison studies. Statistician 32:307–317CrossRef Altman DG, Bland JM (1983) Measurement in medicine: the analysis of method comparison studies. Statistician 32:307–317CrossRef
2.
go back to reference Ansari-Shahrezaei S, Stur M (2005) Magnification-corrected indirect biomicroscopy of the optic nerve head. Graefes Arch Clin Exp Ophthalmol 243:257–262CrossRefPubMed Ansari-Shahrezaei S, Stur M (2005) Magnification-corrected indirect biomicroscopy of the optic nerve head. Graefes Arch Clin Exp Ophthalmol 243:257–262CrossRefPubMed
3.
go back to reference Arnold JV, Gates JWC, Taylor KM (1993) Possible errors in the measurement of retinal lesions. Invest Ophthalmol Vis Sci 34:2576–2580PubMed Arnold JV, Gates JWC, Taylor KM (1993) Possible errors in the measurement of retinal lesions. Invest Ophthalmol Vis Sci 34:2576–2580PubMed
4.
go back to reference Bennett AG, Rudnicka AR, Edgar DF (1994) Improvements on Littmann's method of determining the size of retinal features by fundus photography. Graefes Arch Clin Exp Ophthalmol 232:361–367CrossRefPubMed Bennett AG, Rudnicka AR, Edgar DF (1994) Improvements on Littmann's method of determining the size of retinal features by fundus photography. Graefes Arch Clin Exp Ophthalmol 232:361–367CrossRefPubMed
5.
go back to reference Fankhauser F, Durr U, Giger H, Rol P, Kwasniewska S (1996) Lasers, optical systems and safety in ophthalmology: a review. Graefes Arch Clin Exp Ophthalmol 234:473–487PubMedCrossRef Fankhauser F, Durr U, Giger H, Rol P, Kwasniewska S (1996) Lasers, optical systems and safety in ophthalmology: a review. Graefes Arch Clin Exp Ophthalmol 234:473–487PubMedCrossRef
6.
go back to reference Postelmans L, Pasteels B, Coquelet P, El Quardighi H, Verougstraete C, Schmidt-Erfurth U (2004) Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 138:803–808CrossRefPubMed Postelmans L, Pasteels B, Coquelet P, El Quardighi H, Verougstraete C, Schmidt-Erfurth U (2004) Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females. Am J Ophthalmol 138:803–808CrossRefPubMed
7.
8.
go back to reference Stur M, Ansari-Shahrezaei S (2001) The effect of axial length on laser spot size and laser irradiance. Arch Ophthalmol 119:1323–1328PubMed Stur M, Ansari-Shahrezaei S (2001) The effect of axial length on laser spot size and laser irradiance. Arch Ophthalmol 119:1323–1328PubMed
9.
go back to reference Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP Report 1. Arch Ophthalmol 117:1329–1345 Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP Report 1. Arch Ophthalmol 117:1329–1345
10.
go back to reference Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP Report 2. Arch Ophthalmol 119:198–207 Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP Report 2. Arch Ophthalmol 119:198–207
11.
go back to reference Verteporfin in Photodynamic Therapy (VIP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial—VIP Report 1. Ophthalmology 108:841–852CrossRef Verteporfin in Photodynamic Therapy (VIP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial—VIP Report 1. Ophthalmology 108:841–852CrossRef
12.
go back to reference Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial—VIP report no. 3. Ophthalmology 110:667–673CrossRef Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial—VIP report no. 3. Ophthalmology 110:667–673CrossRef
13.
go back to reference Wachtlin J, Behme T, Heimann H, Kellner U, Foerster MH (2003) Concentric retinal pigment epithelium atrophy after a single photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 241:518–521CrossRefPubMed Wachtlin J, Behme T, Heimann H, Kellner U, Foerster MH (2003) Concentric retinal pigment epithelium atrophy after a single photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 241:518–521CrossRefPubMed
Metadata
Title
The effect of digital measurement software on photodynamic therapy
Authors
Siamak Ansari-Shahrezaei
Erdem Ergun
Michael Stur
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 2/2006
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-005-0128-y

Other articles of this Issue 2/2006

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2006 Go to the issue